Bin1 is linked to metastatic potential and chemosensitivity in neuroblastoma

Pediatric Blood and Cancer

Volumn 53, Issue 3, 2009, Pages 332-337

  Zhong, Xiaoling ^a   Hoelz, Derek J ^a   Kumar, Hari R ^a   Sandoval, John A ^b   Rescorla, Frederick J ^a   Hickey, Robert J ^a   Malkas, Linda H ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Anoikis; Bin1; Chemotherapeutic agent; Marker; Metastasis; Neuroblastoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BRIDGING INTEGRATOR 1 PROTEIN; DOXORUBICIN; PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANOIKIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL KILLING; CELL MOTILITY; CELL PROLIFERATION; CHEMOSENSITIVITY; CYTOTOXICITY; GENE OVEREXPRESSION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; NEUROBLASTOMA; PATIENT CODING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANOIKIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOXORUBICIN; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEUROBLASTOMA; NUCLEAR PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 67651204940     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22068     Document Type: Article

References (34)

1. Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma. Lancet 2007;369:2106-2120.
2. Ara T, DeClerck YA. Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev 2006;25:645-657. (Pubitemid 46071869)
3. DuBois SG, Kalika Y, Lukens JN, et al. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 1999;21:181-189. (Pubitemid 30306028)
4. Bauer F, Urdaci M, Aigle M, et al. Alteration of a yeast SH3 protein leads to conditional viability with defects in cytoskeletal and budding patterns. Mol Cell Biol 1993;13:5070-5084. (Pubitemid 23220410)
5. Sakamuro D, Elliott KJ, Wechsler-Reya R, et al. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat Genet 1996;14:69-77. (Pubitemid 26301549)
6. Butler MH, David C, Ochoa GC, et al. Amphiphysin II (SH3P9; BIN1), a member of the amphiphysin/Rvs family, is concentrated in the cortical cytomatrix of axon initial segments and nodes of ranvier in brain and around T tubules in skeletal muscle. J Cell Biol 1997;137:1355-1367. (Pubitemid 27265947)
7. Prendergast GC, Muller AJ, Ramalingam A, et al. BAR the door: Cancer suppression by amphiphysin-like genes. Biochim Biophys Acta 2009;1795:25-36.
8. Tajiri T, Liu X, Thompson PM, et al. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features. Clin Cancer Res 2003;9:3345-3355. (Pubitemid 37082729)
9. Tajiri T, Tanaka S, Higashi M, et al. Biological diagnosis for neuroblastoma using the combination of highly sensitive analysis of prognostic factors. J Pediatr Surg 2006;41:560-566. (Pubitemid 43330124)
10. Ghaneie A, Zemba-Palko V, Itoh H, et al. Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival. Cancer Biol Ther 2007;6:192-194. (Pubitemid 46641622)
11. Hogarty MD, Liu X, Thompson PM, et al. BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification. Med Pediatr Oncol 2000;35:559-562.
12. Ge K, Duhadaway J, Sakamuro D, et al. Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity. Int J Cancer 2000;85: 376-383. (Pubitemid 30030412)
13. DuHadaway JB, Lynch FJ, Brisbay S, et al. Immunohistochemical analysis of Bin1/Amphiphysin II in human tissues: Diverse sites of nuclear expression and losses in prostate cancer. J Cell Biochem 2003;88:635-642. (Pubitemid 36158282)
14. Ge K, Minhas F, Duhadaway J, et al. Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma. Int J Cancer 2000;86:155-161. (Pubitemid 30180808)
15. Berger JC, Vander Griend DJ, Robinson VL, et al. Metastasis suppressor genes: From gene identification to protein function and regulation. Cancer Biol Ther 2005;4:805-812.
16. Eccles SA, Welch DR. Metastasis: Recent discoveries and novel treatment strategies. Lancet 2007;369:1742-1757. (Pubitemid 46755391)
17. Mehlen P, Puisieux A. Metastasis: A question of life or death. Nat Rev Cancer 2006;6:449-458.
18. Fidler IJ. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003;3:453-458.
19. Fidler IJ, Gersten DM, Hart IR. The biology of cancer invasion and metastasis. Adv Cancer Res 1978;28:149-250.
20. Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol 2001;13:555-562.
21. Gilmore AP. Anoikis. Cell Death Differ 2005;12:1473-1477.
22. Chiarugi P, Giannoni E. Anoikis: A necessary death program for anchorage-dependent cells. Biochem Pharmacol 2008;76:1352-1364.
23. Wong CW, Lee A, Shientag L, et al. Apoptosis: An early event in metastatic inefficiency. Cancer Res 2001;61:333-338. (Pubitemid 32095735)
24. DuHadaway JB, Sakamuro D, Ewert DL, et al. Bin1 mediates apoptosis by c-Myc in transformed primary cells. Cancer Res 2001;61:3151-3156. (Pubitemid 32691968)
25. Wechsler-Reya R, Elliott K, Herlyn M, et al. The putative tumor suppressor BIN1 is a short-lived nuclear phosphoprotein, the localization of which is altered in malignant cells. Cancer Res 1997;57:3258-3263. (Pubitemid 27351744)
26. Ge K, DuHadaway J, Du W, et al. Mechanism for elimination of a tumor suppressor: Aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc Natl Acad Sci USA 1999;96:9689-9694. (Pubitemid 29398793)
27. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: A link between cancer genetics and chemotherapy. Cell 2002;108:153-164.
28. Muller I, Jenner A, Bruchelt G, et al. Effect of concentration on the cytotoxic mechanism of doxorubicin - Apoptosis and oxidative DNA damage. Biochem Biophys Res Commun 1997;230:254-257. (Pubitemid 27211978)
29. Brodeur GM, Seeger RC, Schwab M, et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-1124. (Pubitemid 14106392)
30. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-1116. (Pubitemid 16216827)
31. Schwab M, Amler LC. Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer. Genes Chromosomes Cancer 1990;1:181-193. (Pubitemid 20121808)
32. Spitz R, Hero B, Skowron M, et al. MYCN-status in neuroblastoma: Characteristics of tumours showing amplification, gain, and non-amplification. Eur J Cancer 2004;40:2753-2759. (Pubitemid 39574728)
33. Chang MY, Boulden J, Sutanto-Ward E, et al. Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression. Cancer Res 2007;67:100-107. (Pubitemid 46142764)
34. Stafford LJ, Vaidya KS, Welch DR. Metastasis suppressors genes in cancer. Int J Biochem Cell Biol 2008;40:874-891.